Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | Cancer and Clinical Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2019
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301670217580544 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Cancer and Clinical Oncology |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:61096 |
| institution | FRELIP |
| journal_source_facet | Cancer and Clinical Oncology |
| publishDate | 2019 |
| publishDateSort | 2019 |
| record_format | rss_article |
| spellingShingle | Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy |
| title_auth | Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy |
| title_full | Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy |
| title_fullStr | Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy |
| title_full_unstemmed | Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy |
| title_short | Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy |
| title_sort | treatment of recurrent glioblastoma multiforme (rgbm) with antineoplaston as2-1 in combination with targeted therapy |
| topic | Oncology General Oncology |
| url | https://ccsenet.org/journal/index.php/cco/article/view/0/38361 |